age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
59.92099
|
male
| 0
| 11
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 19,491
| 12,055.1172
| null | 10.5
|
black
| 26.898438
| 22
| 0.47998
| 0.161987
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 6
| 81
| 20.597656
| 72
| 18
| 36.39844
| 118.35938
| 3.599609
| null | 1.599854
| 130
| 7.40918
| null | null | null | null | null |
<2 mo. follow-up
| 3.550781
| 30
| 1
|
58.11899
|
female
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 100
| 40,421
| 20,993.2344
| null | 51
|
white
| 74
| 112
| 0
| 0
| 3
| 0
| 0
|
no
| null | null |
dnr after sadm
| 2
| 15
| 0.899902
| 40
| 20
| 33.09375
| 245
| 2.099609
| 1.399902
| 2.699707
| 127
| 7.40918
| null | null | null | null | null |
<2 mo. follow-up
| 2.151367
| 3
| 1
|
35.25
|
female
| 0
| 38
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 0
| 271,731
| 130,874.125
| null | 26.75
|
white
| 33.296875
| 55
| 0.388977
| 0.269958
| 33
| 0
| 0
|
yes
| null | null |
no dnr
| 38
| 60
| 6.799805
| 135
| 33
| 39
| 128.875
| 3
| 0.199982
| 5.5
| 133
| 7.519531
| null | null | null | null | null | null | 2.286133
| 1,607
| 1
|
66.18994
|
female
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 15
|
under $11k
| 0
| 53,786
| 28,395.1875
| null | 25
|
white
| 23.898438
| 27
| 0.779907
| 0.708984
| 3
| 1
| 0
|
no
| null | null |
no dnr
| 12
| 113
| 13.099609
| 110
| 20
| 36
| 232.5
| null | null | 1.699951
| 143
| 7.429688
| null | null | null | 1
| null |
no(M2 and SIP pres)
| 1.1669
| 635
| 1
|
41.02698
|
male
| 1
| 27
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 16
|
under $11k
| 37
| 237,244
| 115,715.938
| null | 43
|
white
| 41.5
| 59
| 0.339966
| 0.224976
| 3
| 0
| 0
|
no
| 0.8
| 0.7
|
dnr after sadm
| 16
| 57
| 4
| 120
| 18
| 35.19531
| 175
| null | 9.599609
| 2
| 141
| 7.429688
| null | null | null | null | null |
<2 mo. follow-up
| 3.186035
| 27
| 1
|
54.93198
|
male
| 0
| 49
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 12
| null | 0
| null | 215,823.25
| null | 27.75
|
white
| 36
| 46
| 0.431946
| 0.230988
| 3
| 0
| 0
|
no
| 0.1
| 0.001
|
no dnr
| 49
| 43
| 8.5
| 120
| 14
| 38.89844
| 763.25
| null | null | 3.799805
| 145
| 7.55957
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.975586
| 1,701
| 0
|
78.58997
|
male
| 1
| 8
|
Colon Cancer
|
Cancer
| 1
| null | null | 9
| 5,871
| 4,175.8438
| null | 6.5
|
black
| 17.199219
| 24
| 0.761963
| 0.510986
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 1
| 73
| 8.699219
| 90
| 20
| 35.59375
| null | null | null | 1
| 144
| null | null | null | null | null | null |
<2 mo. follow-up
| 3.189941
| 8
| 1
|
82.21497
|
male
| 0
| 37
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 10
|
$11-$25k
| 0
| 135,785
| 73,608.75
| null | 22.25
|
white
| 22.199219
| 30
| 0.744995
| 0.664917
| 3
| 1
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 37
| 63
| 9.398438
| 50
| 14
| 36.59375
| 148
| 3.099609
| 0.899902
| 1.199951
| 143
| 7.509766
| null | null | null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 659
| 1
|
40.34198
|
male
| 1
| 40
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 16
|
>$50k
| 26
| 370,093
| 183,324.25
| null | 29.5
|
white
| 36.796875
| 65
| 0.156982
| 0.076996
| 25
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 37
| 57
| 1.299805
| 140
| 16
| 38.69531
| 184
| null | 1.199951
| 5.799805
| 139
| 7.40918
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 40
| 1
|
60.84097
|
male
| 1
| 23
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 16
| null | 26
| 173,498
| 87,509.5625
| null | 42.666657
|
white
| 31.398438
| 43
| 0.60791
| 0.419983
| 1
| 0
| 0
|
no
| 0.75
| 0.75
|
no dnr
| 23
| 63
| 10.699219
| 110
| 18
| 37.09375
| 120
| 2.899902
| 1.099854
| 1.599854
| 136
| 7.489258
| null | null | null | null | null |
<2 mo. follow-up
| 2.709473
| 23
| 1
|
67.82996
|
male
| 1
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 242,746
| 117,194.312
| null | 46.333313
|
white
| 32.796875
| 54
| 0.478943
| 0.360962
| 6
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 5
| 58
| 9.599609
| 85
| 16
| 39.79688
| 65
| null | null | 5.699219
| 145
| 7.279297
| null | null | null | null | null |
<2 mo. follow-up
| 2.48584
| 19
| 1
|
65.41296
|
female
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 86,956
| 41,667.4375
| null | 49
|
black
| 49
| 99
| 0.141998
| 0.066986
| 4
| 1
| 0
|
no
| 0.2
| 0.2
|
dnr after sadm
| 5
| 57
| 19.699219
| 110
| 90
| 34.5
| 87.5
| null | 4.099609
| 2.5
| 133
| 7.299805
| null | null | null | null | null |
<2 mo. follow-up
| 2.554688
| 7
| 1
|
74.297
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 18
|
>$50k
| 0
| 19,565
| 10,881.6172
| null | 24
|
white
| 29.5
| 53
| 0.672974
| 0.501953
| 1
| 0
| 0
|
no
| 0.5
| 0.25
|
no dnr
| 7
| 62
| 6.5
| 80
| 18
| 37
| 41
| null | null | 2.099609
| 134
| 7.169922
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,690
| 0
|
61.78799
|
female
| 0
| 3
|
Lung Cancer
|
Cancer
| 1
| 12
| null | 0
| 4,226
| null | null | 12
|
black
| 21.597656
| 23
| 0.615967
| 0.300964
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 3
| 93
| 8.099609
| 106
| 24
| 37
| null | null | 0.299988
| 1.599854
| 129
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 2.503906
| 1,690
| 0
|
45.43198
|
male
| 1
| 7
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 16
|
$11-$25k
| 0
| 110,902
| 55,334.2188
| null | 47.5
|
hispanic
| 31.796875
| 57
| 0.426941
| 0.307983
| 18
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 7
| 63
| 11.798828
| 120
| 32
| 37.69531
| 92.21875
| 2.299805
| null | 1.699951
| 136
| 7.5
| null | null | null | null | null |
<2 mo. follow-up
| 2.460449
| 7
| 1
|
62.45297
|
male
| 0
| 43
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 16
|
>$50k
| 0
| 269,517
| 156,722.375
| null | 20
|
white
| 18.097656
| 26
| 0.886963
| 0.810913
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 43
| 63
| 7.899414
| 100
| 20
| 36.59375
| null | null | null | 1.399902
| 134
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,686
| 0
|
70.28094
|
male
| 0
| 12
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 25,535
| 16,605.7656
| null | 12
|
white
| 9.599609
| 17
| 0.888916
| 0.747925
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 12
| 87
| 20.597656
| 76
| 20
| 36.59375
| null | 4.099609
| 0.799927
| 1.299805
| 137
| null | null | null | null | null | null | null | 2.310547
| 659
| 1
|
52.28497
|
female
| 0
| 29
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 16
|
>$50k
| 0
| 303,548
| 185,368.625
| null | 18
|
white
| 35.796875
| 73
| 0.559937
| 0.447998
| 10
| 0
| 0
|
no
| 0.7
| 0.7
|
no dnr
| 29
| 58
| 18.398438
| 170
| 36
| 38.29688
| 173.3125
| 3.799805
| 16.296875
| 1.5
| 141
| 7.479492
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,684
| 0
|
57.76599
|
male
| 0
| 16
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 30,477
| 18,391.8281
| null | 11
|
black
| 26.199219
| 36
| 0.810913
| 0.692993
| 1
| 1
| 0
|
no
| 1
| 0.8
|
no dnr
| 16
| 80
| 11.398438
| 120
| 28
| 36
| 490.4375
| null | 3.5
| 1.299805
| 136
| 7.55957
| null | null | null | null | null | null | 3.303223
| 654
| 1
|
54.74298
|
male
| 1
| 4
|
MOSF w/Malig
|
ARF/MOSF
| 3
| null | null | 44
| 79,089
| 41,714.1562
| null | 22
|
white
| 41.296875
| 55
| 0.023998
| 0.006
| 27
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 2
| 72
| 0.049995
| 110
| 32
| 37.89844
| 91.65625
| 2
| null | 0.599976
| 128
| 7.549805
| null | null | null | null | null |
<2 mo. follow-up
| 3.301758
| 4
| 1
|
54.78198
|
male
| 0
| 7
|
Lung Cancer
|
Cancer
| 2
| null | null | 0
| 7,383
| 4,346.3086
| null | 7
|
black
| 17.296875
| 13
| 0.725952
| 0.451965
| 1
| 1
| 0
|
metastatic
| null | null |
no dnr
| 7
| 88
| 5.899414
| 114
| 22
| 37.39844
| null | null | null | null | 139
| null | null | null | null | 0
| null | null | 0.4948
| 92
| 1
|
46.69998
|
female
| 1
| 3
|
MOSF w/Malig
|
ARF/MOSF
| 2
| null | null | 0
| 105,684
| 53,072.8438
| null | 41
|
other
| 66.5
| 88
| 0
| 0
| 19
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 2
| 28
| 0.099991
| 135
| 35
| 36.09375
| 51
| null | null | 1.5
| 132
| 7.319336
| null | null | null | null | null |
<2 mo. follow-up
| 1.842773
| 3
| 1
|
36.59097
|
male
| 1
| 9
|
MOSF w/Malig
|
ARF/MOSF
| 2
| null | null | 26
| 80,565
| 38,249.9688
| null | 41.5
|
white
| 48.695313
| 98
| 0.022999
| 0.004999
| 3
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 2
| 58
| 0.5
| 140
| 40
| 38.89844
| 95.375
| 3
| 1.699951
| 2.299805
| 128
| 7.279297
| null | null | null | null | null |
<2 mo. follow-up
| 2.697266
| 9
| 1
|
83.39496
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 13
|
$11-$25k
| 0
| 3,968
| 2,632.3965
| null | 9
|
black
| 10.599609
| 27
| 0.900879
| 0.833984
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 77
| 5.699219
| 80
| 22
| 37.19531
| null | 4.099609
| 0.699951
| 1.5
| 141
| null | null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,682
| 0
|
41.29797
|
female
| 1
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
| null | 37
| 182,264
| 94,687.875
| null | 29.333328
|
black
| 36.195313
| 59
| 0.414978
| 0.294983
| 22
| 1
| 0
|
no
| 0.8
| 0.75
|
dnr after sadm
| 18
| 52
| 25.699219
| 140
| 10
| 39
| 282.8125
| 2.599609
| 0.399963
| 4.699219
| 128
| 7.40918
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 18
| 1
|
90.13794
|
male
| 0
| 27
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 24
| null | 44
| 124,700
| 63,788.7812
| null | 23.5
| null | 26.199219
| 61
| 0.184998
| 0.096985
| 26
| 0
| 0
|
metastatic
| 0
| 0
|
dnr before sadm
| -5
| 63
| 25.199219
| 65
| 28
| 36.5
| 172.5
| 2
| 2.899902
| 1.799805
| 138
| 7.479492
| null | null | null | null | null |
<2 mo. follow-up
| 5.729492
| 53
| 1
|
20.09599
|
female
| 0
| 18
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$11-$25k
| 0
| 51,152
| null | null | 16.666656
|
black
| 25.5
| 37
| 0.910889
| 0.849976
| 2
| 1
| 0
|
no
| 1
| 0.75
|
no dnr
| 18
| 63
| 16.5
| 125
| 32
| 39
| null | null | null | 1.399902
| 130
| null | null | null | null | 0
| 2
|
no(M2 and SIP pres)
| 2
| 365
| 1
|
38.92999
|
male
| 0
| 4
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 14
|
$25-$50k
| 0
| 4,117
| 2,564.5
| null | 5
|
white
| 23.296875
| 27
| 0.849976
| 0.75293
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 96
| 6.899414
| 92
| 22
| 38.39844
| null | 2.599609
| 8.298828
| 0.799927
| 129
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,681
| 0
|
39.81897
|
male
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 100
| 79,944
| 41,072.2812
| null | 38
|
white
| 66
| 105
| 0
| 0
| 16
| 0
| 0
|
no
| null | null |
dnr after sadm
| 3
| 23
| 38.09375
| 135
| 48
| 36.39844
| 130
| 4.399414
| 5.699219
| 3.799805
| 138
| 7.199219
| null | null | null | null | null |
<2 mo. follow-up
| 3.044434
| 3
| 1
|
53.09497
|
female
| 1
| 6
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 0
| null | null | 100
| 47,800
| 23,203.7656
| null | 36
|
white
| 43.898438
| 78
| 0.002
| 0
| 3
| 0
| 0
|
no
| null | null |
dnr after sadm
| 1
| 65
| 22.199219
| 195
| 22
| 40
| 150
| null | 34.5
| 2.299805
| 137
| 7.519531
| null | null | null | null | null |
<2 mo. follow-up
| 3.597656
| 6
| 1
|
53.38498
|
female
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 11
|
under $11k
| 0
| 81,459
| 58,011.0938
| null | 17
|
white
| 32.296875
| 52
| 0.694946
| 0.603882
| 2
| 0
| 0
|
no
| null | null |
no dnr
| 13
| 73
| 5.199219
| 120
| 12
| 38.39844
| 190
| 3.899902
| 0.299988
| 7.399414
| 128
| 7.359375
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.726563
| 1,676
| 0
|
79.81396
|
male
| 0
| 22
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 13
|
$25-$50k
| 37
| 98,268
| 50,717.0312
| null | 28.666656
|
white
| 34
| 53
| 0.286987
| 0.176971
| 3
| 1
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 7
| 102
| 15.898438
| 135
| 12
| 38.5
| 122
| 2.899902
| 2.799805
| 2.699707
| 144
| 7.30957
| null | null | null | null | null |
adl>=4 (>=5 if sur)
| 3.371582
| 650
| 1
|
68.45996
|
female
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null |
under $11k
| 41
| 26,493
| 14,291.1875
| null | 10
|
black
| 15.199219
| 16
| 0.720947
| 0.634888
| 1
| 0
| 0
|
metastatic
| 0.1
| 0.001
|
dnr after sadm
| 1
| 100
| 7.299805
| 60
| 22
| 37.79688
| 222
| null | 0.799927
| 0.699951
| 138
| 7.469727
| null | null | null | null | null |
adl>=4 (>=5 if sur)
| 3.908203
| 136
| 1
|
52.52597
|
female
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 16
|
$11-$25k
| 0
| 20,605
| 12,221.1406
| null | 15
|
black
| 17.398438
| 28
| 0.912964
| 0.852905
| 1
| 0
| 0
|
no
| 0.5
| 0.3
|
no dnr
| 8
| 63
| 6
| 65
| 20
| 36.39844
| 400
| 4
| 0.399963
| 2.699707
| 136
| 7.339844
| null | null | null | 6
| 3
|
adl>=4 (>=5 if sur)
| 3
| 1,206
| 1
|
62.50198
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 4
|
$11-$25k
| 0
| 8,761
| 5,023.8125
| null | 7
|
hispanic
| 17.699219
| 26
| 0.889893
| 0.814941
| 1
| 1
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 4
| 70
| 9.298828
| 60
| 20
| 36
| 352.375
| null | 0.299988
| 1.5
| 138
| 7.449219
| null | null | null | null | null | null | 2.504395
| 595
| 1
|
57.02899
|
male
| 0
| 27
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 17
|
$11-$25k
| 26
| 145,874
| 74,736.375
| null | 30
|
white
| 27.199219
| 44
| 0.462952
| 0.260986
| 2
| 0
| 0
|
yes
| 0.5
| 0
|
dnr after sadm
| 17
| 67
| 5.099609
| 130
| 25
| 37
| 212.5
| 2.5
| 8.398438
| 1.099854
| 136
| 7.55957
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 45
| 1
|
61.448
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 3
|
under $11k
| 0
| 13,444
| 7,088.8398
| null | 12
|
black
| 12.898438
| 20
| 0.924927
| 0.873901
| 1
| 0
| 0
|
no
| 0.95
| 0.8
|
no dnr
| 8
| 117
| 7
| 82
| 28
| 36.59375
| 428.5625
| 3.899902
| 1.099854
| 1.199951
| 139
| 7.469727
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 608
| 1
|
87.76697
|
female
| 0
| 28
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 16
|
under $11k
| 37
| 109,552
| 53,782.9062
| null | 25.25
|
white
| 31.796875
| 54
| 0.243988
| 0.084991
| 1
| 0
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 1
| 55
| 23.796875
| 165
| 36
| 37.79688
| 273.3125
| 3
| null | 0.5
| 143
| 7.299805
| null | null | null | null | null |
<2 mo. follow-up
| 4.458984
| 57
| 1
|
65.71399
|
male
| 1
| 6
|
Coma
|
Coma
| 2
| null | null | 55
| 45,707
| 21,547.7344
| null | 37
|
white
| 41.296875
| 72
| 0.032997
| 0.014999
| 1
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 5
| 43
| 14.898438
| 80
| 26
| 38.89844
| 174
| null | 9.898438
| 7.699219
| 137
| 7.449219
| null | null | null | null | null |
<2 mo. follow-up
| 2.753418
| 6
| 1
|
46.97098
|
female
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 9
|
under $11k
| 0
| 5,975
| 3,269.1504
| null | 8
|
hispanic
| 13.5
| 9
| 0.954956
| 0.922974
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 112
| 8.199219
| 72
| 20
| 37.59375
| 238.09375
| null | null | 0.799927
| 139
| 7.419922
| null | null | null | 2
| null | null | 1.839
| 1,666
| 0
|
62.10797
|
male
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 7
|
under $11k
| 0
| 22,091
| 13,650.9375
| null | 11.5
|
white
| 13.298828
| 16
| 0.921997
| 0.868896
| 1
| 0
| 0
|
no
| 0.5
| 0.3
|
no dnr
| 11
| 95
| 5.5
| 75
| 22
| 36
| null | 3.899902
| null | 1.299805
| 138
| null | null | null | null | 2
| 5
|
SIP>=30
| 5
| 664
| 1
|
81.99896
|
female
| 1
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 41
| 117,689
| 53,773.375
| null | 27
|
white
| 25.296875
| 37
| 0.481995
| 0.363953
| 5
| 0
| 0
|
no
| 0.75
| 0.5
|
dnr after sadm
| 13
| 65
| 31.199219
| 50
| 26
| 36.79688
| 331.375
| 3.799805
| 1.099854
| 1.899902
| 133
| 7.519531
| null | null | null | null | null |
<2 mo. follow-up
| 3.946777
| 17
| 1
|
62.53
|
female
| 0
| 16
|
Colon Cancer
|
Cancer
| 1
| 12
| null | 0
| 16,862
| 10,397.3203
| null | 10.666664
|
white
| 12.699219
| 7
| 0.870972
| 0.709961
| 1
| 0
| 0
|
metastatic
| 0.85
| 0.9
|
no dnr
| 16
| 97
| 5.099609
| 96
| 20
| 37.39844
| 342.8125
| 3.799805
| 0.799927
| 0.799927
| 134
| 7.489258
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 130
| 1
|
54.52197
|
female
| 0
| 145
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 13
|
>$50k
| 0
| 414,803
| null | null | 17
|
white
| 38.796875
| 54
| 0.579956
| 0.385986
| 1
| 0
| 0
|
no
| 0.8
| 0.5
|
no dnr
| 145
| 37
| 7.5
| 90
| 24
| 36.29688
| 122.5
| 3.399902
| 1.599854
| 1.399902
| 135
| 7.469727
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,664
| 0
|
49.87
|
male
| 1
| 5
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 0
| 59,913
| 29,431.5938
| null | 46
|
white
| 47.796875
| 94
| 0.084
| 0.031998
| 2
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 4
| 57
| 0.099991
| 165
| 28
| 41.19531
| 85
| 2.5
| 2.099609
| 1.699951
| 133
| 7.30957
| null | null | null | null | null |
<2 mo. follow-up
| 2.226563
| 5
| 1
|
61.69199
|
female
| 0
| 25
|
Colon Cancer
|
Cancer
| 2
| 12
|
$11-$25k
| 0
| 75,618
| 41,915.4688
| null | 10.5
|
white
| 17.199219
| 32
| 0.819946
| 0.610962
| 1
| 0
| 0
|
metastatic
| 0.85
| 0.7
|
no dnr
| 25
| 103
| 10.398438
| 106
| 24
| 38.19531
| null | 3.799805
| 0.299988
| 2.399902
| 141
| null | null | null | null | 6
| null |
no(M2 and SIP pres)
| 4.527397
| 292
| 1
|
39.14899
|
female
| 0
| 37
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$25-$50k
| 0
| 147,711
| null | null | 24
|
black
| 22.5
| 31
| 0.901978
| 0.835938
| 1
| 0
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 37
| 58
| 6.199219
| 105
| 34
| 36.69531
| null | null | 0.799927
| 0.899902
| 130
| null | null | null | null | 5
| 4
| null | 4
| 945
| 1
|
50.45599
|
female
| 1
| 9
|
MOSF w/Malig
|
ARF/MOSF
| 2
| null | null | 0
| 202,111
| 102,048.125
| null | 46.5
|
white
| 41.5
| 71
| 0.136993
| 0.063995
| 29
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 5
| 63
| 0.899902
| 115
| 16
| 38.19531
| 89.21875
| 2.799805
| 4.199219
| 2.399902
| 143
| 7.459961
| null | null | null | null | null |
<2 mo. follow-up
| 2.55957
| 9
| 1
|
50.57599
|
female
| 0
| 46
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 10
| null | 0
| 303,934
| 139,610.125
| null | 32.5
|
white
| 40.898438
| 74
| 0.381958
| 0.185974
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 46
| 55
| 5.299805
| 75
| 12
| 36.19531
| 443.3125
| 2.199707
| 44.398438
| 5.099609
| 147
| 7.229492
| null | null | null | null | 2
|
no(M2 and SIP pres)
| 2
| 1,657
| 0
|
68.80798
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 14
|
under $11k
| 0
| 7,354
| 4,315.8477
| null | 8
|
black
| 20.898438
| 25
| 0.839966
| 0.736938
| 1
| 1
| 0
|
no
| 0.95
| 0.85
|
no dnr
| 4
| 94
| 5.399414
| 84
| 20
| 36.39844
| 576
| null | null | 1.699951
| 128
| 7.459961
| null | null | null | 4
| null |
SIP>=30
| 3.183199
| 870
| 1
|
46.07797
|
male
| 0
| 41
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 18
|
>$50k
| 44
| 353,422
| 190,804
| null | 35.5
|
white
| 50
| 72
| 0.003
| 0
| 2
| 0
| 0
|
metastatic
| null | null |
no dnr
| 41
| 63
| 3.599609
| 170
| 10
| 35.29688
| 160
| 3.599609
| 51.296875
| 5
| 147
| 7.589844
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 313
| 1
|
79.16498
|
female
| 0
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null |
under $11k
| 0
| 3,974
| 2,517.9512
| null | 8
|
white
| 14.099609
| 21
| 0.881958
| 0.802979
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 3
| 139
| 6.199219
| 76
| 24
| 36.39844
| 466.625
| null | null | 1
| 141
| 7.459961
| null | null | null | null | null | null | 2.249512
| 1,655
| 0
|
81.758
|
female
| 0
| 15
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 0
| 22,800
| 13,578.2578
| null | 8.666664
|
white
| 20.898438
| 41
| 0.792969
| 0.666992
| 1
| 0
| 0
|
no
| 0.6
| 0.216
|
no dnr
| 15
| 110
| 11.199219
| 80
| 24
| 36.39844
| 285.6875
| null | 0.299988
| 1.599854
| 128
| 7.519531
| null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 36
| 1
|
76.98798
|
female
| 0
| 36
|
COPD
|
COPD/CHF/Cirrhosis
| 0
| 16
| null | 0
| 113,045
| null | null | 10.25
|
white
| 37.195313
| 51
| 0.380981
| 0.184998
| 2
| 0
| 0
|
no
| 0.5
| 0.3
|
dnr after sadm
| 7
| 48
| 12.099609
| 170
| 28
| 36.5
| 155
| null | null | 0.599976
| 134
| 7.40918
| null | null | null | null | 5
| null | 5
| 1,655
| 0
|
81.66498
|
female
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 17
|
$11-$25k
| 41
| 31,827
| 16,880.5469
| null | 22
|
white
| 17.398438
| 19
| 0.701904
| 0.611938
| 3
| 0
| 0
|
no
| 0.7
| 0.6
|
dnr after sadm
| 2
| 97
| 22.097656
| 100
| 24
| 38.39844
| 225.6875
| null | null | 1
| 135
| 7.449219
| null | null | null | null | null |
<2 mo. follow-up
| 3.646484
| 6
| 1
|
54.26999
|
male
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 16
|
under $11k
| 0
| 44,608
| 22,993.125
| null | 15
|
white
| 33.296875
| 46
| 0.669922
| 0.573975
| 2
| 0
| 0
|
no
| null | null |
no dnr
| 13
| 107
| 7.099609
| 125
| 28
| 36
| 120.40625
| null | 1.199951
| 2.299805
| 138
| 7.5
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,654
| 0
|
22.825
|
male
| 1
| 10
|
MOSF w/Malig
|
ARF/MOSF
| 3
| null | null | 0
| 254,601
| 115,477.625
| null | 49.5
|
white
| 53.195313
| 80
| 0.004
| 0
| 29
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 10
| 43
| 2.899902
| 145
| 28
| 38.69531
| 146
| null | 6.5
| 4.299805
| 139
| 7.359375
| null | null | null | null | null |
<2 mo. follow-up
| 2.966309
| 10
| 1
|
58.43698
|
female
| 0
| 11
|
Colon Cancer
|
Cancer
| 1
| 20
|
>$50k
| 0
| 14,670
| 9,659.4062
| null | 8
|
white
| 13.298828
| 19
| 0.869995
| 0.708984
| 1
| 0
| 0
|
metastatic
| 0.75
| 0.25
|
dnr after sadm
| 2
| 65
| 7.199219
| 72
| 12
| 37
| null | 3.799805
| 0.699951
| 0.699951
| 135
| null | null | null | null | 2
| null | null | 1.839
| 271
| 1
|
58.28598
|
male
| 0
| 10
|
Colon Cancer
|
Cancer
| 1
| 14
|
>$50k
| 0
| 24,073
| 15,612.7109
| null | 11
|
white
| 3.799805
| 9
| 0.937988
| 0.852905
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.8
|
no dnr
| 10
| 81
| 11.798828
| 72
| 22
| 38.89844
| null | 4.399414
| 0.599976
| 1
| 139
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 872
| 1
|
84.29297
|
female
| 0
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 5,110
| 3,391.9277
| null | 14
|
white
| 21.597656
| 22
| 0.770996
| 0.634888
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 3
| 103
| 9.398438
| 130
| 20
| 36
| 423.75
| null | null | 1.299805
| 137
| 7.609375
| null | null | null | null | null | null | 3.057129
| 1,291
| 1
|
47.01999
|
male
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 44
| 56,169
| 28,008.9219
| null | 31
|
white
| 49.398438
| 73
| 0.088989
| 0.034996
| 2
| 0
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 9
| 28
| 10
| 110
| 26
| 36.29688
| 148.3125
| null | null | 12
| 149
| 7.479492
| null | null | null | null | null |
<2 mo. follow-up
| 3.171875
| 10
| 1
|
42.28897
|
female
| 0
| 6
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 15
|
$11-$25k
| 0
| 6,057
| 3,922.8438
| null | 5
|
white
| 21.796875
| 38
| 0.852905
| 0.756958
| 1
| 0
| 0
|
no
| 0.7
| 0.7
|
no dnr
| 6
| 70
| 2.599609
| 72
| 20
| 37
| null | 2.799805
| 11.898438
| 0.899902
| 133
| null | null | null | null | 1
| null |
no(M2 and SIP pres)
| 1.1669
| 1,649
| 0
|
86.37097
|
male
| 0
| 14
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 14,836
| 9,444.3281
| null | 6.666664
|
white
| 18.296875
| 32
| 0.812988
| 0.696899
| 1
| 0
| 0
|
no
| 0.75
| 0.5
|
no dnr
| 14
| 107
| 4.299805
| 80
| 20
| 36.79688
| null | 3.599609
| 0.699951
| 2.5
| 135
| null | null | null | null | null | null | null | 4.03125
| 1,649
| 0
|
72.23499
|
male
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 16
|
>$50k
| 0
| 23,972
| 13,201.7969
| null | 13
|
white
| 32.796875
| 37
| 0.60498
| 0.498962
| 1
| 1
| 0
|
no
| 0.5
| 0.2
|
dnr after sadm
| 1
| 95
| 6.099609
| 98
| 26
| 37.79688
| 83.32812
| 3
| 1.399902
| 1.899902
| 157
| 7.439453
| null | null | null | null | 6
|
adl>=4 (>=5 if sur)
| 6
| 579
| 1
|
85.35199
|
female
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 239,683
| 122,276.312
| null | 41.5
|
white
| 63.09375
| 95
| 0
| 0
| 26
| 0
| 0
|
no
| 0.05
| 0.000125
|
dnr before sadm
| -1
| 33
| 14
| 120
| 35
| 35.89844
| 170
| 3.799805
| 35.695313
| 2.599609
| 137
| 7.5
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 7
| 1
|
49.13898
|
female
| 0
| 12
|
Lung Cancer
|
Cancer
| 1
| 12
|
under $11k
| 0
| 17,775
| 10,275.0859
| null | 9
|
black
| 26.597656
| 35
| 0.523926
| 0.201996
| 1
| 0
| 0
|
metastatic
| 0.2
| 0.05
|
dnr after sadm
| 2
| 55
| 9.099609
| 122
| 28
| 38.29688
| null | null | null | 0.699951
| 129
| null | null | null | null | 3
| 5
|
adl>=4 (>=5 if sur)
| 5
| 85
| 1
|
79.04395
|
female
| 1
| 15
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 36,520
| 16,195.8438
| null | 11.333328
|
white
| 25.898438
| 51
| 0.615967
| 0.429993
| 1
| 0
| 0
|
yes
| 0.6
| 0.4
|
dnr after sadm
| 2
| 120
| 9.298828
| 110
| 26
| 36.39844
| 110
| 3.699707
| null | 0.899902
| 139
| 7.179688
| null | null | null | null | null |
<2 mo. follow-up
| 4.448242
| 15
| 1
|
41.61798
|
male
| 1
| 19
|
MOSF w/Malig
|
ARF/MOSF
| 2
| null | null | 37
| 161,755
| 71,957.1875
| null | 30.333328
|
white
| 33.09375
| 59
| 0.324951
| 0.210999
| 1
| 0
| 0
|
yes
| 0.2
| 1
|
dnr after sadm
| 9
| 127
| 3.199707
| 200
| 38
| 36.39844
| 179
| null | 2.5
| 1.199951
| 149
| 7.369141
| null | null | null | null | null |
<2 mo. follow-up
| 2.968262
| 19
| 1
|
25.49199
|
female
| 1
| 4
|
MOSF w/Malig
|
ARF/MOSF
| 2
| null | null | 26
| 359,124
| 168,043.625
| null | 31
|
white
| 42.296875
| 55
| 0.061996
| 0.021
| 80
| 0
| 0
|
yes
| 0.2
| 0.2
|
dnr after sadm
| 3
| 103
| 2.799805
| 145
| 46
| 39
| 109.32812
| null | 3.099609
| 1.099854
| 125
| 7.469727
| null | null | null | null | null |
<2 mo. follow-up
| 2.663086
| 4
| 1
|
50.754
|
male
| 1
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 100
| 448,431
| 236,295.25
| null | 33
|
white
| 43
| 59
| 0.009998
| 0.002
| 27
| 0
| 0
|
no
| 0.25
| 0.25
|
dnr after sadm
| 13
| 42
| 10.699219
| 118
| 12
| 38.89844
| 270
| 3.599609
| 13.699219
| 1.699951
| 131
| 7.509766
| null | null | null | null | null |
<2 mo. follow-up
| 3.865723
| 18
| 1
|
53.09198
|
female
| 0
| 7
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 12
|
>$50k
| 0
| 13,434
| 6,912.5508
| null | 8
|
white
| 28.699219
| 35
| 0.679932
| 0.510986
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 7
| 66
| 13.199219
| 102
| 20
| 36.59375
| null | 2.399902
| 5.299805
| 1.199951
| 124
| null | null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,642
| 0
|
75.80798
|
male
| 0
| 26
|
Lung Cancer
|
Cancer
| 2
| 3
|
>$50k
| 26
| 73,798
| 39,726.125
| null | 10.5
|
white
| 38
| 78
| 0.030998
| 0
| 3
| 0
| 0
|
metastatic
| 0.4
| 0.05
|
dnr after sadm
| 12
| 137
| 29.199219
| 160
| 56
| 38
| 146
| 2.799805
| null | 1.099854
| 143
| 7.469727
| null | null | null | null | 4
|
<2 mo. follow-up
| 4
| 29
| 1
|
75.99695
|
male
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 13
|
$11-$25k
| 0
| 99,364
| 46,090.7812
| null | 53
|
white
| 42.898438
| 81
| 0.244995
| 0.141998
| 3
| 0
| 0
|
no
| null | null |
dnr after sadm
| 6
| 52
| 23.296875
| 150
| 44
| 37
| 170
| null | 3.899902
| 4.5
| 134
| 7.389648
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 6
| 1
|
54.491
|
male
| 0
| 6
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 9,974
| 5,706.2227
| null | 10
|
white
| 24.5
| 25
| 0.750977
| 0.605957
| 1
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 6
| 95
| 6.899414
| 78
| 18
| 36.39844
| null | 2.399902
| 5.599609
| 0.899902
| 125
| null | null | null | null | null | null | null | 3.331055
| 1,638
| 0
|
27.51799
|
female
| 1
| 6
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
| null | 37
| 132,130
| 64,562.0938
| null | 46
|
hispanic
| 34.09375
| 81
| 0.202972
| 0.109985
| 20
| 0
| 0
|
yes
| 0.5
| 0.5
|
dnr after sadm
| 5
| 76
| 2.799805
| 200
| 56
| 38.39844
| 277
| null | 1.399902
| 2.699707
| 136
| 7.289062
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 6
| 1
|
59.62198
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 2
| 12
|
>$50k
| 0
| 11,765
| 5,337.5898
| null | 10
|
white
| 19.898438
| 15
| 0.660889
| 0.358948
| 1
| 1
| 0
|
metastatic
| 1
| 0.5
|
no dnr
| 4
| 96
| 11.699219
| 104
| 20
| 36.19531
| null | null | null | 1.199951
| 135
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 274
| 1
|
78.12695
|
female
| 1
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
|
$11-$25k
| 100
| 107,073
| 49,515.3125
| null | 34.666657
|
white
| 25.5
| 44
| 0.242981
| 0.140991
| 2
| 0
| 1
|
no
| 0
| 0
|
no dnr
| 23
| 60
| 24.097656
| 70
| 44
| 38.89844
| 96.65625
| 2
| null | 1.099854
| 141
| 7.429688
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 23
| 1
|
30.023
|
male
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 15
|
$25-$50k
| 0
| 108,131
| 52,857.5625
| null | 24.666656
|
white
| 24
| 16
| 0.888916
| 0.848999
| 2
| 0
| 0
|
no
| null | null |
no dnr
| 17
| 97
| 4.899414
| 110
| 12
| 38.59375
| 267.5
| 3.099609
| 5.799805
| 1.099854
| 141
| 7.439453
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.086914
| 1,636
| 0
|
52.70099
|
female
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 14
|
$25-$50k
| 0
| 6,521
| 4,240.2422
| null | 6
|
white
| 5.699219
| 9
| 0.884888
| 0.737915
| 1
| 0
| 0
|
metastatic
| 0.7
| 0.15
|
no dnr
| 4
| 80
| 9.199219
| 64
| 20
| 36.39844
| null | 4.299805
| 0.399963
| 1
| 140
| null | null | null | null | 1
| null |
no(M2 and SIP pres)
| 1.1669
| 370
| 1
|
52.767
|
male
| 1
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 10
| null | 0
| 45,767
| 22,561.2812
| null | 16
|
black
| 29.699219
| 47
| 0.764893
| 0.689941
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 11
| 77
| 17.097656
| 115
| 24
| 38.19531
| 208.5625
| 3.399902
| 4
| 5.399414
| 145
| 7.449219
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 11
| 1
|
50.38199
|
female
| 0
| 14
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 11
|
under $11k
| 0
| 25,748
| 15,329.3125
| null | 9.666664
|
black
| 18.796875
| 9
| 0.906982
| 0.843994
| 1
| 0
| 0
|
no
| 0.75
| 0.6
|
no dnr
| 14
| 60
| null | 50
| 20
| 36.09375
| null | null | null | 0.799927
| 138
| null | null | null | null | 0
| 5
|
adl>=4 (>=5 if sur)
| 5
| 1,629
| 0
|
37.336
|
female
| 1
| 6
|
MOSF w/Malig
|
ARF/MOSF
| 2
| null | null | 0
| 168,270
| 83,700.5
| null | 48
|
other
| 39.695313
| 80
| 0.205994
| 0.112
| 23
| 0
| 0
|
yes
| 0.8
| 0.8
|
dnr after sadm
| 3
| 57
| 1.899902
| 140
| 14
| 38.5
| 231.65625
| 3.299805
| 7.5
| 5.699219
| 145
| 7.299805
| null | null | null | null | null |
<2 mo. follow-up
| 2.454102
| 6
| 1
|
65.57697
|
male
| 0
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 16
| null | 0
| 42,780
| 20,734.2188
| null | 19.5
|
white
| 20.296875
| 38
| 0.827881
| 0.718994
| 5
| 0
| 0
|
no
| null | null |
no dnr
| 10
| 52
| 3.799805
| 70
| 30
| 38.29688
| 251.40625
| null | null | 1.5
| 142
| 7.529297
| null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 12
| 1
|
42.29398
|
male
| 1
| 5
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4
| null | null | 44
| 49,389
| 24,999.875
| null | 37
|
white
| 39.195313
| 73
| 0.244995
| 0.085999
| 3
| 0
| 0
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 5
| 67
| 23.597656
| 130
| 32
| 36.5
| 167.5
| 3.199707
| 8
| 2.599609
| 134
| 7.529297
| null | null | null | null | null |
<2 mo. follow-up
| 3.955078
| 5
| 1
|
55.31799
|
female
| 0
| 12
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 12
|
$11-$25k
| 0
| 16,717
| 9,094.3281
| null | 7
|
white
| 25.398438
| 24
| 0.728882
| 0.575928
| 1
| 0
| 0
|
no
| 0.5
| 0.3
|
no dnr
| 12
| 120
| 7.5
| 80
| 18
| 37.59375
| null | 2.5
| 3.699707
| 0.599976
| 121
| null | null | null | null | 2
| null | null | 1.839
| 68
| 1
|
51.89899
|
female
| 1
| 4
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 61
| 85,777
| 39,979
| null | 23
| null | 35.695313
| 40
| 0.026997
| 0.007
| 14
| 0
| 0
|
metastatic
| null | null |
dnr before sadm
| -9
| 40
| 3.799805
| 120
| 34
| 38.19531
| null | null | null | null | 138
| null | null | null | null | null | null |
<2 mo. follow-up
| 3.771973
| 4
| 1
|
48.98599
|
male
| 1
| 16
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 5
| null | null | 0
| 131,400
| 60,309.4688
| null | 38
|
white
| 29.296875
| 50
| 0.644897
| 0.465942
| 5
| 0
| 0
|
no
| null | null |
dnr after sadm
| 10
| 60
| 16.398438
| 115
| 36
| 38
| 132
| 2.399902
| 4.199219
| 1
| 138
| 7.549805
| null | null | null | null | null |
<2 mo. follow-up
| 3.510742
| 16
| 1
|
76.33398
|
male
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 7
|
under $11k
| 0
| 24,988
| 13,437.4375
| null | 19
|
white
| 14.699219
| 32
| 0.882935
| 0.804932
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 11
| 60
| 5.799805
| 72
| 20
| 36.19531
| null | 4
| 2.099609
| 1.5
| 144
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 93
| 1
|
24.493
|
male
| 0
| 37
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 0
| 149,776
| 73,399.875
| null | 28
|
white
| 28.898438
| 41
| 0.836914
| 0.780884
| 5
| 0
| 0
|
no
| 0.98
| 0.98
|
no dnr
| 37
| 108
| 29.796875
| 140
| 10
| 38.69531
| 394.25
| 2.299805
| 7.599609
| 0.799927
| 132
| 7.449219
| null | null | null | null | 0
|
SIP>=30
| 0
| 1,619
| 0
|
70.46698
|
female
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 16
|
$25-$50k
| 9
| 57,539
| 31,008.5938
| null | 14.333328
|
other
| 32.398438
| 50
| 0.517944
| 0.401978
| 5
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 14
| 135
| 5.099609
| 120
| 26
| 37.69531
| 195.90625
| null | null | 2.299805
| 128
| 7.439453
| null | null | null | null | null | null | 3.690918
| 717
| 1
|
58.31897
|
male
| 0
| 87
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 23
| null | 26
| 542,326
| null | null | 41
|
white
| 33.898438
| 40
| 0.295959
| 0.184998
| 2
| 0
| 0
|
yes
| 0.4
| 0.1
|
dnr before sadm
| -1
| 112
| 4.299805
| 205
| 15
| 37.69531
| 52
| 3.399902
| 1.899902
| 0.899902
| 137
| 7.279297
| null | null | null | null | null |
adl>=4 (>=5 if sur)
| 2.641602
| 98
| 1
|
80.25494
|
female
| 1
| 5
|
Coma
|
Coma
| 2
| null | null | 94
| 14,297
| 6,564.4648
| null | 19
|
white
| 23.398438
| 34
| 0.118988
| 0.07399
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 4
| 127
| 13.599609
| 135
| 32
| 38.89844
| 357.125
| null | null | 0.599976
| 138
| 7.469727
| null | null | null | null | null |
<2 mo. follow-up
| 3.553223
| 5
| 1
|
67.58398
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 3
| 12
|
$11-$25k
| 0
| 10,819
| 5,204.7305
| null | 17
|
black
| 17.699219
| 18
| 0.687988
| 0.395996
| 1
| 0
| 0
|
metastatic
| 0.6
| 0.3
|
no dnr
| 4
| 97
| 12
| 80
| 20
| 35.79688
| null | null | null | 1.199951
| 135
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 2.794434
| 482
| 1
|
40.96399
|
male
| 1
| 7
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 16
|
$11-$25k
| 26
| 93,417
| 48,108.6875
| null | 35.5
|
hispanic
| 35.296875
| 55
| 0.435974
| 0.234985
| 6
| 0
| 0
|
no
| null | null |
dnr after sadm
| 7
| 70
| 2.299805
| 95
| 14
| 36.69531
| 271.375
| 3.599609
| 38.398438
| 4.699219
| 136
| 7.389648
| null | null | null | null | null |
<2 mo. follow-up
| 3.133301
| 7
| 1
|
26.683
|
female
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 11
| null | 41
| 109,747
| 51,558
| null | 30
|
other
| 38.195313
| 48
| 0.559937
| 0.447998
| 1
| 0
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 19
| 118
| 24.097656
| 120
| 10
| 38
| 58.32812
| 2.399902
| 12.599609
| 1.399902
| 136
| 7.449219
| null | null | null | null | 0
| null | 0
| 1,611
| 0
|
61.85397
|
female
| 1
| 21
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 11
|
under $11k
| 9
| 173,968
| 93,752.5625
| null | 23.666656
|
white
| 35.296875
| 78
| 0.25
| 0.145996
| 15
| 0
| 0
|
yes
| 0.5
| 0.4
|
dnr after sadm
| 20
| 113
| 0.049995
| 180
| 28
| 39.69531
| 352.375
| 2.099609
| 2.299805
| 1.799805
| 134
| 7.549805
| null | null | null | null | null |
<2 mo. follow-up
| 3.466309
| 21
| 1
|
77.53595
|
male
| 1
| 3
|
Coma
|
Coma
| 0
| null | null | 100
| 20,078
| 9,221.7812
| null | 42
|
white
| 48.796875
| 67
| 0
| 0
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 2
| 40
| 10.398438
| 55
| 10
| 35.59375
| 64
| 3.899902
| 1.299805
| 2.299805
| 138
| 7.239258
| null | null | null | null | null |
<2 mo. follow-up
| 2.995606
| 3
| 1
|
70.03998
|
female
| 1
| 35
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
| null | 26
| 444,556
| 233,671.25
| null | 19.5
|
white
| 23.796875
| 40
| 0.555908
| 0.44397
| 14
| 0
| 0
|
yes
| null | null |
no dnr
| 35
| 93
| 10.599609
| 105
| 32
| 39
| 288
| 4.099609
| 3.599609
| 1.099854
| 132
| 7.269531
| null | null | null | null | 4
|
<2 mo. follow-up
| 4
| 35
| 1
|
66.00098
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$25-$50k
| 0
| 31,463
| 15,501.3281
| null | 9
|
white
| 15.798828
| 40
| 0.896973
| 0.827881
| 1
| 0
| 0
|
no
| 0.6
| 0.5
|
no dnr
| 7
| 57
| 8.699219
| 115
| 22
| 36.5
| null | 4.799805
| 0.399963
| 1.599854
| 135
| null | null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,608
| 0
|
59.995
|
female
| 0
| 14
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 8
| null | 0
| 41,479
| 17,930.9219
| null | 15.666664
|
hispanic
| 19.398438
| 32
| 0.861938
| 0.771973
| 1
| 0
| 0
|
yes
| 0.7
| 0.6
|
no dnr
| 14
| 77
| 4.199219
| 95
| 40
| 36.19531
| 266.625
| null | 0.099991
| 0.899902
| 133
| 7.319336
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 642
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.